Search Results - "Kebenko M"

Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study.

Authors: Preyer L Vettorazzi E Fiedler W et al.

Source: Frontiers in oncology [Front Oncol] 2024 Oct 17; Vol. 14, pp. 1429221. Date of Electronic Publication: 2024 Oct 17 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Case report: Tenosynovial giant cell tumor.

Authors: Fähnrich A Gasimova Z Maluje Y et al.

Source: Frontiers in oncology [Front Oncol] 2024 Sep 26; Vol. 14, pp. 1445427. Date of Electronic Publication: 2024 Sep 26 (Print Publication: 2024).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Androgen receptor expression in glioblastoma: molecular profiling and association with tumor burden.

Authors: Liubych L Hahn L Hollnagel R et al.

Source: Molecular biology reports [Mol Biol Rep] 2026 Mar 24; Vol. 53 (1). Date of Electronic Publication: 2026 Mar 24.

Publication Type: Journal Article

Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

Therapeutic Potential of an Anti-CD44v6 Monoclonal Antibody in Xenograft Models of Colorectal and Gastric Cancer.

Authors: Hirayama, Aoi Tanaka, Tomohiro Ohishi, Tomokazu et al.

Source: Cells (2073-4409). Dec2025, Vol. 14 Issue 23, p1873. 14p.

Intravascular Lipoleiomyoma With Expansion Into the Right Atrium and Subsequent Debulking Surgery.

Authors: Traub A Vorwerk J Morf J et al.

Source: JACC. Case reports [JACC Case Rep] 2025 Jun 18; Vol. 30 (15), pp. 103764.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: Netherlands NLM ID: 101757292 Publication Model: Print Cited Medium: Internet ISSN: 2666-0849 (Electronic) Linking ISSN: 26660849 NLM ISO Abbreviation: JACC Case Rep Subsets: PubMed not MEDLINE

Revealing cancer driver genes through integrative transcriptomic and epigenomic analyses with Moonlight.

Authors: Nourbakhsh, Mona Zheng, Yuanning Noor, Humaira et al.

Source: PLoS Computational Biology. 4/21/2025, Vol. 21 Issue 4, p1-20. 20p.

A comparative analysis of tumor markers reveals EDA fibronectin as a promising target in high-grade serous ovarian cancer.

Authors: Piermattei, Alessia De Luca, Roberto Peissert, Frederik et al.

Source: Journal of Ovarian Research. 8/26/2025, Vol. 18 Issue 1, p1-11. 11p.

Leveraging diverse liquid–liquid phase separation patterns to predict the prognosis and immunotherapy of pediatric acute myeloid leukemia.

Authors: Kong, Min Yang, Yezhen Wu, Zhixiang et al.

Source: BMC Cancer. 8/18/2025, Vol. 25 Issue 1, p1-18. 18p.

Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study.

Authors: Ön, Sercan Köksal, Barış Arık, Zafer et al.

Source: Current Oncology. Nov2024, Vol. 31 Issue 11, p6803-6813. 11p.

Advances in Immunotherapies for Targeting Cancer Stem Cells in a Tumor Microenvironment: Emerging Strategies and Clinical Prospects.

Authors: Oh, Nakyung Trinh, Van Ngu

Source: Cells (2073-4409). May2026, Vol. 15 Issue 10, p910. 42p.

Engineering Organ-on-a-Chip Systems for Cancer Immunotherapy: Strategies and Assay Integration.

Authors: Wang, Jie Wang, Zongjie

Source: Bioengineering (Basel). May2026, Vol. 13 Issue 5, p492. 25p.

Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 Years.

Authors: Capria, Saveria Trisolini, Silvia Maria Torrieri, Lorenzo et al.

Source: Cancers. Aug2024, Vol. 16 Issue 16, p2864. 11p.

A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug Resistance.

Authors: Ladikou, Eleni E. Sharp, Kim Simoes, Fabio A. et al.

Source: Cancers. Jan2025, Vol. 17 Issue 1, p135. 18p.

Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas.

Authors: Ishikawa, Kenichiro Suzuki, Hiroyuki Ohishi, Tomokazu et al.

Source: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9190. 16p.

Multiprotein-based nanomedicines with dual CD44/CD133 targeting and GSH-responsive drug release for improving cancer chemotherapy.

Authors: Yu LY Shueng PW Wang YH et al.

Source: Drug delivery and translational research [Drug Deliv Transl Res] 2026 May 11. Date of Electronic Publication: 2026 May 11.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE

Novel molecular mechanisms of FLT3 deregulation: from the acute myeloid leukemia experience to therapeutic insights in acute lymphoblastic leukemia.

Authors: Lo Schiavo, F. Salvesi, C. Jandoubi, M. et al.

Source: Molecular Cancer. 10/22/2025, Vol. 24 Issue 1, p1-25. 25p.

Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies.

Authors: Yang, Ge Massumi, Mohammad

Source: Antibodies (2073-4468). Sep2025, Vol. 14 Issue 3, p52. 53p.

Soft Tissue Sarcomas: Treatment and Management.

Authors: Miwa, Shinji Wu, Po-Kuei Tsuchiya, Hiroyuki

Source: Cancers. Mar2024, Vol. 16 Issue 5, p1042. 5p.

Bispecific antibodies: unleashing a new era in oncology treatment.

Authors: Shui, Lin Wu, Dan Yang, Kaixuan et al.

Source: Molecular Cancer. 8/4/2025, Vol. 24 Issue 1, p1-36. 36p.

Bispecific Antibodies in Solid Tumors: Advances and Challenges.

Authors: Shan, Khine Swe Musleh Ud Din, Saba Dalal, Shivani et al.

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 12, p5838. 39p.